European Society of Cardiology: cardiovascular disease statistics 2021

A Timmis, P Vardas, N Townsend… - European heart …, 2022 - academic.oup.com
Aims This report from the European Society of Cardiology (ESC) Atlas Project updates and
expands upon the widely cited 2019 report in presenting cardiovascular disease (CVD) …

[HTML][HTML] Primary stroke prevention worldwide: translating evidence into action

MO Owolabi, AG Thrift, A Mahal, M Ishida… - The Lancet Public …, 2022 - thelancet.com
Stroke is the second leading cause of death and the third leading cause of disability
worldwide and its burden is increasing rapidly in low-income and middle-income countries …

[HTML][HTML] Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

GBD Collaborators, VL Feigin, BA Stark… - The Lancet …, 2021 - escholarship.org
BackgroundRegularly updated data on stroke and its pathological types, including data on
their incidence, prevalence, mortality, disability, risk factors, and epidemiological trends, are …

[HTML][HTML] Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

VL Feigin, BA Stark, CO Johnson, GA Roth… - The Lancet …, 2021 - thelancet.com
Background Regularly updated data on stroke and its pathological types, including data on
their incidence, prevalence, mortality, disability, risk factors, and epidemiological trends, are …

[HTML][HTML] Stroke in Africa: profile, progress, prospects and priorities

RO Akinyemi, B Ovbiagele, OA Adeniji… - Nature Reviews …, 2021 - nature.com
Stroke is a leading cause of disability, dementia and death worldwide. Approximately 70% of
deaths from stroke and 87% of stroke-related disability occur in low-income and middle …

The global burden of neurological disorders: translating evidence into policy

VL Feigin, T Vos, E Nichols, MO Owolabi… - The Lancet …, 2020 - thelancet.com
Neurological disorders are the leading cause of disability and the second leading cause of
death worldwide. In the past 30 years, the absolute numbers of deaths and people with …

[HTML][HTML] The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the …

AF Awedew, H Han, B Abbasi… - The Lancet Healthy …, 2022 - thelancet.com
Background Benign prostatic hyperplasia is a common urological disease affecting older
men worldwide, but comprehensive data about the global, regional, and national burden of …

European Stroke Organisation (ESO) guideline on pharmacological interventions for long-term secondary prevention after ischaemic stroke or transient ischaemic …

J Dawson, Y Béjot, LM Christensen… - European stroke …, 2022 - journals.sagepub.com
Recurrent stroke affects 9% to 15% of people within 1 year. This European Stroke
Organisation (ESO) guideline provides evidence-based recommendations on …

Early versus delayed non–vitamin k antagonist oral anticoagulant therapy after acute ischemic stroke in atrial fibrillation (TIMING): a registry-based randomized …

J Oldgren, S Åsberg, Z Hijazi, P Wester, M Bertilsson… - Circulation, 2022 - Am Heart Assoc
Background: There are no evidence-based recommendations on the optimal time point to
initiate non–vitamin K antagonist oral anticoagulants (NOACs) after acute ischemic stroke in …

Preventing dementia by preventing stroke: the Berlin Manifesto

V Hachinski, K Einhäupl, D Ganten, S Alladi… - Alzheimer's & …, 2019 - Elsevier
The incidence of stroke and dementia are diverging across the world, rising for those in low-
and middle-income countries and falling in those in high-income countries. This suggests …